How reorganizing existing drugs and vaccine components can dramatically alter their potency, selectivity, and even their ...
Developing materials used across General Atomics, this lab is onshoring nuclear-grade SiC fiber, innovating SiC foam and ...
Scientists have developed a breakthrough injectable biomaterial that travels through the bloodstream to repair damaged tissue ...
Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of ...
New solutions include customized reagents that scale from bench to clinical trials, industrialized lentiviral vector ...
Lung cancer treatment and outcomes are profoundly influenced by the tumor microenvironment (TME), particularly in resectable ...
Organogenesis initiated the rolling BLA submission in December 2025 with non-clinical modules and has now completed the application with the submission of the clinical and chemistry, manufacturing, ...
Among the many short peptides that have attracted sustained scientific curiosity, glycyl-L-histidyl-L-lysine complexed with ...
Scientists reveal how humans can regrow fingertips, showing that soft, hyaluronic acid-rich tissue environments drive bone, ...
Human tumor organoids have advanced cancer modeling by preserving patient-specific heterogeneity and functional drug responses. However, translating organoid findings into routine decision-making ...
Mouse analog of MICVO (maMICVO) monotherapy produced dose-dependent inhibition of tumor growth in a syngeneic preclinical model of HNSCCmaMICVO ...